National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

78 Protocols (58 Active Accrual of new subjects, 20 Follow-up of previously enrolled subjects)

 08-DK-0187:

Natural History and Pathophysiology of Gastrointestinal Graft Versus Host Disease

 08-DK-0182:

Viral Kinetics and Liver Gene Expression in Response to Ribavirin and Peginterferon Therapy of Chronic Hepatitis C

 08-DK-0173:

A Trial of Segmental Stiffening Wires to Improve the Efficiency and Patient Tolerability of Colonoscopy

 08-DK-0165:

Thyroid Hormones Homeostasis and Energy Metabolism Changes During Stimulation of Endogenously Secreted Bile Acids (BAs)

 08-DK-0157:

A Trial of Oral Nifedipine for the Treatment of Iron Overload

 08-DK-0149:

High Dose Ribavirin in Combination with Peginterferon for Patients with Chronic Hepatitis C Genotype 1 Infection Who Have Failed to Respond or Relapsed After Standard Therapy

 08-DK-0138:

A New Method for Determining Gastric Acid Output Using a Wireless Capsule

 08-DK-0106:

Hepatitis C Eradication and Progression of Atherosclerosis

 08-DK-0098:

Natural History of Familial Carcinoid Tumor

 08-DK-0004:

High Throughput Screening of Compound Libraries to Discover a Drug for the Treatment of Sickle Cell Disease

 07-DK-0219:

A Nutrigenomics Intervention for the Study of the Role of Dietary Sitosterol on Lipid, Glucose and Energy Metabolism

 07-DK-0212:

Prospective Evaluation of Albuminuria in HIV Positive Patients

 07-DK-0207:

Tenofovir Disoproxil Fumarate Alone Versus its Combination with Emtricitabine for Treatment of Chronic Hepatitis B

 07-DK-0202:

Thyroid Hormones Homeostasis and Energy Metabolism Changes During Exposure to Cold Temperature in Humans

 07-DK-0163:

The Effect of Diet on Vascular Disease: A Study of Pre-Menopausal African Amercian and Caucasian Women

 07-DK-0143:

Effects of S-Adenosyl Methionine (SAMe) on Viral and Cell Signaling Response to Combination Therapy for Chronic Hepatitis C

 07-DK-0115:

Effect of Short-Term Beta-Cell Rest in Adolescents and Young Adults with Type 2 Diabetes Mellitus

 07-DK-0077:

Study of the Phenotype of Overweight and Obese Adults

 06-DK-0183:

Gene Expression and Release of Inflammatory Mediators in Overweight Subjects Before and After Weight Loss

 06-DK-0142:

Peripheral Blood Collection of Adult Stem Cells

 06-DK-0133:

Thyroid Hormone-Induced Lipolysis: An In Vivo Microdialysis Study

 06-DK-0079:

The Role of the Orexin System in Body Weight Regulation: Patients with Narcolepsy

 06-DK-0036:

Chronic Sleep Deprivation as a Risk Factor for Metabolic Syndrome and Obesity

 06-DK-0025:

The Effects of Lithium Carbonate on Low Dose Radioiodine Ablation in Early Thyroid Cancer Treatment

 06-DK-0020:

Kidney Disease Biomarkers

 05-DK-0119:

Peripheral Thyroid Hormone Conversion and Glucose and Energy Metabolism

 05-DK-0085:

Clinical and Laboratory Investigation of Humans with Informative Iron or Erythroid Phenotypes

 05-DK-0015:

Retinoids for Podocyte Disease

 04-DK-0061:

A Comparison of Free Fatty Acid Flux in African Americans and Caucasians

 04-DK-0021:

Urinary Vitamin C Loss in Subjects with and without Diabetes

 03-DK-0257:

Effect of Leptin Therapy in the Treatment of Severe Insulin Resistance

 03-DK-0256:

Inhibition of Intestinal Glucose Absorption by the Bioflavonoid Quercetin in the Obese and in Obese Type 2 Diabetics

 03-DK-0226:

Pulse Dexamethasone Over 48 Weeks for Podocyte Disease

 03-DK-0098:

Study of Thyrotropin Releasing Hormone in Patients with Thyroid or Pituitary Abnormalities

 02-DK-0107:

Investigation of Neurodegeneration in Glycosphingolipid Storage Disorders

 02-DK-0022:

Long-Term Efficacy of Leptin Replacement in Treatment of Lipodystrophy

 01-DK-0247:

Treatment of Chronic Delta Hepatitis with Pegylated Interferon

 01-DK-0088:

Determining the Prevalence and Prognosis of Secondary Pulmonary Hypertension in Adult Patients with Sickle Cell Anemia

 01-DK-0062:

Genetic Analysis of Familial Keloids

 01-DK-0053:

Permeability Factor in Focal Segmental Glomerulosclerosis

 00-DK-0221:

Evaluation of the Immune Response in Humans After Exposure to Hepatitis C Virus

 00-DK-0125:

Immunogenetics of Hepatitis C Virus Infection

 00-DK-0107:

Search for Novel Methods to Detect Acute Renal Failure

 99-DK-0119:

Monitoring for Donor-Specific Hyporesponsiveness Following Renal and Pancreatic Allotransplantation

 99-DK-0002:

Heart Disease Risk Factors in African Americans

 94-DK-0133:

Genetic Markers for Focal Segmental Glomerulosclerosis

 94-DK-0127:

Pathogenesis of Glomerulosclerosis

 93-DK-0127:

Family Studies in Metabolic Diseases and Mineral Metabolism

 92-DK-0156:

Studies of Immunologically-Mediated Kidney Diseases

 91-DK-0085:

Studies of Hyperparathyroidism and Related Disorders

 91-DK-0066:

Fasting Hypoglycemia: Diagnosis and Treatment

 89-DK-0173:

Studies of States with Resistance to Vitamin D and Parathyroid Hormone

 89-DK-0152:

Determination of Glomerular Filtration Rate, Effective Renal Plasma Flow and Glomerular Capillary Wall Permselectivity

 87-DK-0029:

Diagnosis and Treatment of Patients with Cystic Fibrosis and Other Disorders of the Respiratory System and Pancreas

 85-DK-0082:

Acromegaly Treatment and Natural History

 77-DK-0096:

Studies on Thyroid Nodules and Thyroid Cancer

 77-DK-0002:

Evaluation of Patients with Thyroid Function Disorders

 76-DK-0006:

Studies of Molecular Genetics of Insulin Secretion, Insulin Action, and Diabetes Mellitus

 04-DK-0193:

Identification and Mechanistic Investigations of Tolerant Kidney Transplant Patients

 04-DK-0099:

Depletional Induction with Rabbit Anti-Thymocyte Globulin, Followed by Two Approaches Toward Monotherapy Immunosuppression in Kidney Transplant Recipients

 04-DK-0057:

Renal Transplantation in Recipients with Nephropathic Cystinosis

 03-DK-0245:

Effect of AC2993 (Synthetic Exendin-4) - Administered Alone or in Combination with Daclizumab - On Islet Function in Patients with Type I Diabetes

 03-DK-0212:

Long-Term Treatment of Nonalcoholic Steatohepatitis With Pioglitazone

 03-DK-0136:

Low Dose Peginterferon and Ribavirin Therapy for Patients with Chronic Hepatitis C Infected with Genotype 2 or 3

 03-DK-0132:

The Pathogenesis of Chronic Graft Failure after Kidney Transplantation

 03-DK-0071:

Sirolimus Therapy in Idiopathic and Lupus Membranous Nephropathy

 02-DK-0065:

Combination of Pegylated Interferon and Ribavirin as Therapy for Patients with Chronic Hepatitis C with and without Renal Disease

 01-DK-0249:

Ingested Interferon-Alpha: Prolongation or Permanence of the "Honeymoon" Phase in Newly Diagnosed Diabetes Mellitus

 01-DK-0246:

Combination of Lamivudine and Adefovir Dipivoxil for Treatment of Chronic Hepatitis B

 01-DK-0036:

Solitary Islet Transplantation for Type 1 Diabetes Mellitus Using Steroid Sparing Immunosuppression

 00-DK-0196:

Sirolimus Monotherapy to Optimize Activation Induced Cell Death (AICD) in Renal Transplants Following Lymphocyte Depletion Induction with Thymoglobulin

 00-DK-0186:

The Hep C Antiviral Long-Term Tx Against Cirrhosis (HALT-C) Trial: A Randomized Controlled Trial to Evaluate the Safety & Efficacy of Long-Term Peginterferon Alpha2A for Tx of Chronic Hep C in Patients Who Failed to Respond to Previous Interferon Therap

 00-DK-0042:

Pirfenidone in Focal Segmental Glomerulosclerosis:Phase II Study

 99-DK-0120:

Screening Protocol for Patients Needing a Kidney, Kidney-Pancreas, or Islet Cell Transplant

 99-DK-0107:

Live Donor Renal Donation for Allotransplantation

 92-DK-0033:

Pharmacokinetics and Biodistribution of Ascorbic Acid in Healthy Human Subjects

 90-DK-0137:

Evaluation of the Gastrinoma in Patients with Zollinger-Ellison Syndrome

 76-DK-0081:

Studies with 1,25-Dihydroxycholecalciferol

Search The Studies | Help | Questions |
Clinical Center Home | NIH Home

National Institutes of Health Clinical Center
Bethesda, Maryland 20892. Last update: 09/17/2008